Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Erich Miltner
Targeted Alpha-Therapy Using [Bi-213]anti-Cd20 as Novel Treatment Option for Radio- And Chemoresistant Non-Hodgkin Lymphoma Cells
Oncotarget
Oncology
Related publications
Bendamustine-Based Therapy as First-Line Treatment for Non-Hodgkin Lymphoma
Medical Oncology
Medicine
Cancer Research
Oncology
Hematology
Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Improving the Treatment of Non-Hodgkin Lymphoma With Antibody-Targeted Radionuclides
Cancer
Cancer Research
Oncology
CD30-targeted Oncolytic Viruses as Novel Therapeutic Approach Against Classical Hodgkin Lymphoma
Oncotarget
Oncology
Regulation of CD20 in Rituximab-Resistant Cell Lines and B-Cell Non-Hodgkin Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
Antibody-Targeted Paclitaxel Loaded Nanoparticles for the Treatment of CD20+ B-Cell Lymphoma
Scientific Reports
Multidisciplinary
A Novel Immunomodulatory and Molecularly Targeted Strategy for Refractory Hodgkin’s Lymphoma
Oncotarget
Oncology
Novel Treatment Strategies for Patients With Relapsed Classical Hodgkin Lymphoma
Blood Reviews
Oncology
Hematology
Non-Hodgkin Lymphoma